Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 145.00
-1.00 (-0.68%)
May 13, 2025, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 9.75 billion as of May 13, 2025. Its market cap has decreased by -54.45% in one year.
Market Cap
9.75B
Enterprise Value
7.32B
Revenue
5.82M
Ranking
n/a
PE Ratio
536.75
Stock Price
145.00
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 9.75B, an increase of 280.23%. That is a compound annual growth rate of 33.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 9.69B | 2.47% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | 2.79B | 8.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 166.19B |
| Caliway Biopharmaceuticals | 119.20B |
| Bora Pharmaceuticals Co., LTD. | 73.49B |
| Lotus Pharmaceutical | 60.56B |
| Polaris Group | 32.43B |
| Oneness Biotech | 29.46B |
| Pegavision | 27.14B |
| Lumosa Therapeutics | 26.85B |